4//SEC Filing
Sapir Alex 4
Accession 0000950170-24-025933
CIK 0001680581other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:15 PM ET
Size
5.1 KB
Accession
0000950170-24-025933
Insider Transaction Report
Form 4
Sapir Alex
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2024-03-04$11.35/sh+43,360$492,028→ 43,360 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.96 to $11.50, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001709415
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:15 PM ET
- Size
- 5.1 KB